UBS Asset Management Americas Inc. raised its position in HealthSouth Corp. (NYSE:HLS) by 1.2% during the second quarter, Holdings Channel reports. The fund owned 64,934 shares of the company’s stock after buying an additional 784 shares during the period. UBS Asset Management Americas Inc. owned approximately 0.07% of HealthSouth Corp. worth $2,521,000 at the end of the most recent reporting period.
Other institutional investors have also bought and sold shares of the company. Acrospire Investment Management LLC acquired a new position in HealthSouth Corp. during the first quarter worth approximately $105,000. Creative Planning boosted its position in HealthSouth Corp. by 2.0% in the second quarter. Creative Planning now owns 2,858 shares of the company’s stock worth $111,000 after buying an additional 56 shares during the last quarter. Societe Generale acquired a new position in HealthSouth Corp. during the second quarter worth approximately $172,000. BNP Paribas Arbitrage SA boosted its position in HealthSouth Corp. by 7,088.4% in the second quarter. BNP Paribas Arbitrage SA now owns 4,960 shares of the company’s stock worth $193,000 after buying an additional 4,891 shares during the last quarter. Finally, Opus Capital Group LLC acquired a new position in HealthSouth Corp. during the second quarter worth approximately $207,000. Institutional investors and hedge funds own 94.94% of the company’s stock.
HealthSouth Corp. (NYSE:HLS) traded down 0.20% during mid-day trading on Friday, hitting $40.49. 119,540 shares of the stock traded hands. The company’s 50 day moving average is $40.64 and its 200 day moving average is $39.82. HealthSouth Corp. has a 12 month low of $30.26 and a 12 month high of $43.38. The company has a market cap of $3.63 billion, a P/E ratio of 17.77 and a beta of 1.02.
HealthSouth Corp. (NYSE:HLS) last released its quarterly earnings data on Thursday, July 28th. The company reported $0.69 earnings per share for the quarter, beating the consensus estimate of $0.60 by $0.09. HealthSouth Corp. had a net margin of 6.26% and a return on equity of 28.99%. The firm earned $920.70 million during the quarter, compared to analysts’ expectations of $906.67 million. During the same period in the previous year, the company earned $0.47 earnings per share. The firm’s quarterly revenue was up 20.4% on a year-over-year basis. On average, analysts expect that HealthSouth Corp. will post $2.52 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Monday, October 17th. Stockholders of record on Monday, October 3rd will be issued a dividend of $0.24 per share. This represents a $0.96 annualized dividend and a dividend yield of 2.37%. This is a boost from HealthSouth Corp.’s previous quarterly dividend of $0.23. The ex-dividend date is Thursday, September 29th. HealthSouth Corp.’s payout ratio is presently 42.29%.
HLS has been the subject of a number of research analyst reports. Zacks Investment Research upgraded HealthSouth Corp. from a “hold” rating to a “buy” rating and set a $47.00 price target for the company in a report on Monday, August 1st. SunTrust Banks Inc. set a $54.00 price objective on HealthSouth Corp. and gave the stock a “buy” rating in a report on Monday, August 1st. Wells Fargo & Co. restated a “buy” rating on shares of HealthSouth Corp. in a report on Sunday, September 11th. JMP Securities restated a “buy” rating on shares of HealthSouth Corp. in a report on Sunday, September 4th. Finally, Barclays PLC cut HealthSouth Corp. from an “equal weight” rating to an “underweight” rating and reduced their price objective for the stock from $45.00 to $42.00 in a report on Monday, June 27th. They noted that the move was a valuation call. One research analyst has rated the stock with a sell rating, three have issued a hold rating and seven have assigned a buy rating to the stock. HealthSouth Corp. currently has a consensus rating of “Buy” and a consensus target price of $46.00.
In other HealthSouth Corp. news, COO Mark J. Tarr sold 20,000 shares of the company’s stock in a transaction that occurred on Tuesday, August 2nd. The shares were sold at an average price of $41.85, for a total transaction of $837,000.00. Following the completion of the sale, the chief operating officer now directly owns 252,519 shares of the company’s stock, valued at $10,567,920.15. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Insiders own 5.00% of the company’s stock.
About HealthSouth Corp.
HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in over 30 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company’s segments include inpatient rehabilitation, and home health and hospice.
Want to see what other hedge funds are holding HLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthSouth Corp. (NYSE:HLS).
Receive News & Ratings for HealthSouth Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth Corp. and related companies with MarketBeat.com's FREE daily email newsletter.